{"summary": "a novel betacoronavirus was isolated from a fatal case of pneumonia with renal failure. the new virus was commonly referred to as severe respiratory syndrome coronavirus (SARS)-like virus. the virus has been confirmed in 150 cases with 64 deaths to date. the mechanism of action for MPA remains under debate. data suggest that MPA may have both direct antiviral activity and indirect activity through modulation of IFN response activities. ELISA was developed to screen candidate antivirals for MERS-CoV. signal-to-noise ratios (S/N) between mock-infected cells (noise; m.o.i. 0) and infected cells (signal; m.o.i. 0.03, 0.1, or 0.3) are shown for the indicated m.o.i. results shown are representative of one experiment (meansd, n = 4). further analysis at lower concentrations confirmed strong inhibition of MERS-CoV replication with MPA at an IC50 of 2.87 M. inhibition of MERS-CoV with MPA is in contrast to the reported inability of MPA to inhibit SARS-CoV infection with MPA. results are representative of one experiment (meansd, n = 4) the experiment was repeated at least twice. strong anti-MERS-CoV activity was observed in lower dose range. antiviral activity of IFN- (IC50 = 1.37 U ml1) was 16-, 41-, 83- and 117-fold higher than those of IFN-2b, IFN-, IFN-universal type 1 and IFN-2a respectively. the ability of IFN- to inhibit MERS-CoV growth was confirmed in a virus yield reduction assay. results are representative of one experiment (meansd, n = 4) the experiment was repeated at least twice. the experiment was repeated at least twice. both IFN- and MPA have been approved by the FDA for other indications. both drugs are readily available and can be used off label at the discretion of the clinician. there have been a number of proposed mechanisms of action for MPA. test compounds MPA and ribavirin were obtained from Sigma-Aldrich. a recombinant product based on the consensus sequence of the IFN- subtypes designated \u2018universal type 1 IFN\u2019 were obtained from PBL. m.o.i. of 0.1 in 50 l DMEM plus 10 % FBS approximately 1 h after the addition of the drugs. plates were fixed with 10 % neutral-buffered formalin and removed from biocontainment. the percentage inhibition of treated wells (TREAT) compared with untreated wells (UNTR) was determined using the formula: % inhibition = [1(TREATnormal)/(UNTRnormal)]100. the signal from treated wells was normalized to uninfected control wells. supernatants were collected and titrated using the infectivity assay. the assay was carried out with three replicates for each drug concentration. cytopathic effect was scored by fixing and staining the cells with crystal violet. vero cells were seeded using 40 000 cells in 100 l DMEM plus 10 % FBS per well in black-, opaque- or clear-bottomed 96-well plates. test compounds MPA and ribavirin were obtained from Sigma-Aldrich. after 24 h, five dilutions of test compounds were added to the cells. system was used to quantify fluorescence of both dyes, Alexa Fluor 594 and Hoechst 33342. wavelengths of 360\u2013400 and 560\u2013580 nm were used to excite dye. the plates were analysed using a cellTiter Glo luminescent cell viability assay kit. luminescence was read on an Infinite M1000 Pro plate reader. fluorescent stain Hoechst 33342 (Life Technologies) was used to determine cell numbers in each well. vero E6 cells were seeded using 40 000 cells in 100 l DMEM plus 10 % FBS per well in black-, opaque- or clear-bottomed 96-well plates. test compounds MPA and ribavirin were obtained from Sigma-Aldrich. MERS-CoV was detected with a rabbit polyclonal antibody to the HCoV-EMC/2012 S protein (Sino Biological) followed by staining with Alexa Fluor 594-conjugated goat anti-rabbit IgG (H+L) antibody (Life Technologies) fected control wells (normal) and measured (as a %) relative to untreated wells. the assay was carried out with four replicates for each drug concentration. the assay was repeated twice for confirmation. vero E6 cells were infected in eight replicates with 10-fold dilutions of supernatants from the virus yield reduction assay. MERS-CoV was absorbed for 1 h, and then removed and replaced with DMEM plus 10 % FBS."}